Reducing the immunogenicity of fusion proteins
First Claim
Patent Images
1. A nucleic acid encoding a fusion protein with reduced immunogenicity comprising:
- a non-immunoglobulin protein andan immunoglobulin protein fused to said non-immunoglobulin protein via a fusion junction,wherein the amino acid sequence of a junction region surrounding the fusion junction comprises an IgG sequence having an ATAT amino acid sequence (amino acids 3-6 of SEQ ID NO;
6) instead of an LSLS amino acid sequence (amino acids 3-6 of SEQ ID NO;
5).
4 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are compositions and methods for producing fusion proteins with reduced immunogenicity. Fusion proteins of the invention include a junction region having an amino acid change that reduces the ability of a junctional epitope to bind to MHC Class II, thereby reducing its interaction with a T-cell receptor. Methods of the invention involve analyzing, changing, or modifying one or more amino acids in the junction region of a fusion protein in order to identify a T-cell epitope and reduce its ability to interact with a T cell receptor. Compositions and methods of the invention are useful in therapy.
-
Citations
2 Claims
-
1. A nucleic acid encoding a fusion protein with reduced immunogenicity comprising:
-
a non-immunoglobulin protein and an immunoglobulin protein fused to said non-immunoglobulin protein via a fusion junction, wherein the amino acid sequence of a junction region surrounding the fusion junction comprises an IgG sequence having an ATAT amino acid sequence (amino acids 3-6 of SEQ ID NO;
6) instead of an LSLS amino acid sequence (amino acids 3-6 of SEQ ID NO;
5).
-
-
2. A nucleic acid encoding a fusion protein with reduced immunogenicity comprising:
-
a non-immunoglobulin protein and an immunoglobulin protein fused to said non-immunoglobulin protein via a fusion junction, wherein the amino acid sequence of a junction region surrounding the fusion junction comprises an IgG region wherein an LSLS amino acid sequence (amino acids 3-6 of SEQ ID NO;
5) is mutated without generating a T-cell epitope.
-
Specification